Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2024-10-22 | D/A | $150M | 5 | |
| 2025-10-21 | D/A | $150M | 5 | $0 |
| 2026-10-21 | D/A | $686.2M | 506 | +$536.2M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$536.2M, +501 investors) in 365 days since the previous filing.
| N/A AG CSF2 (Annex) Dislocation Fund GP, LLC | Executive Officer, Director, Promoter |
| Martin Davidson | Executive Officer |
| Christopher Moore | Executive Officer |
| Jean-Baptiste Garcia | Executive Officer |
| Joann Harris | Executive Officer |
| Frank Stadelmaier | Executive Officer |
| Steven Willmann | Executive Officer |
| Adam Schwartz | Executive Officer |
| Brian Sigman | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Christopher Moore, General Counsel of Manager of the General Partner.
Relevant to: Fund audit & tax, Fund administrator.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
